Categories
BPI-9016M

BPI-9016M

HY-114356
1528546-94-2

$431.0 / 10 mM * 1 mL in DMSO

MCE
Emibetuzumab

Emibetuzumab

HY-P99192
1365287-97-3

MCE
Rilotumumab

Rilotumumab

HY-P99217
872514-65-3

$310.0 / 1mg

MCE
Ficlatuzumab

Ficlatuzumab

HY-P99196
1174900-84-5

$180.0 / 1mg

MCE
Onartuzumab

Onartuzumab

HY-P99250
1133766-06-9

MCE
Narnatumab

Narnatumab

HY-P99375
1188275-92-4

MCE
(rel)-Tivantinib

(rel)-Tivantinib

HY-77493
905853-99-8

$154.0 / 10 mM * 1 mL in DMSO

MCE
Davutamig

Davutamig

HY-P990073
2648058-48-2

$600.0 / 1mg

MCE
c-Met-IN-18

c-Met-IN-18

HY-149880
3034863-56-1

MCE
Tepotinib

Tepotinib

HY-14721
1100598-32-0

$103.0 / 10 mM * 1 mL in DMSO

MCE
Dihexa

Dihexa

HY-16969
1401708-83-5

$200.0 / 10 mM * 1 mL in DMSO

MCE
c-Met-IN-2

c-Met-IN-2

HY-101773
1635406-73-3

MCE
Ensartinib

Ensartinib

HY-103714
1370651-20-9

$185.0 / 10 mM * 1 mL in DMSO

MCE
c-Met-IN-1

c-Met-IN-1

HY-101031
2084836-84-8

MCE
Meleagrin

Meleagrin

HY-N6797
71751-77-4

$280.0 / 1mg

MCE
PF-04217903 phenolsulfonate

PF-04217903 phenolsulfonate

HY-12017B
1159490-85-3

MCE
Norleual

Norleual

HY-P1415
334994-34-2

MCE
MET kinase-IN-2

MET kinase-IN-2

HY-131065
2101241-90-9

$322.0 / 10 mM * 1 mL in DMSO

MCE
c-Met-IN-9

c-Met-IN-9

HY-115937
2760326-29-0

MCE
AC-386

AC-386

HY-143463
1902910-89-7

MCE